Teva Amphetamine Tablets Recalled Due To Incorrect Strength Labeling
Teva Pharmaceuticals is recalling 83,703 bottles of prescription amphetamine tablets nationwide because bottles labeled as 15 mg strength actually contain 20 mg tablets, creating risk of unintended overdose. Patients should contact their pharmacy or healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a FDA Class II recall of a controlled prescription drug with significant strength mislabeling (labeled 15 mg, actual 20 mg), creating risk of unintended overdose. However, no illnesses or injuries have been reported, making the hazard theoretical rather than documented.
Plain-English summary
Teva Pharmaceuticals USA Inc is recalling mixed amphetamine salts tablets (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate) due to a labeling error. The recalled product is a 100-count bottle labeled as 15 mg strength but actually containing 20 mg tablets.
The labeling error means that patients taking this medication could unknowingly receive a higher dose than prescribed. Affected bottles bear lot number 100023340 with an expiration date of October 2024.
This recall affects nationwide distribution in the United States. Approximately 83,703 bottles were distributed. Consumers taking this medication should immediately contact their pharmacy or healthcare provider to confirm whether they have received affected product.
Patients should not continue taking tablets from the recalled lot without consulting their healthcare provider about the strength discrepancy. Healthcare providers and pharmacies should identify and quarantine affected stock.
The recalled product
- Product
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE)
- Brand
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Category
- Drug — Prescription Amphetamine
- Hazard
- Affected units
- 83,703
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 100023340
- Exp 10/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- HighAmphetamine salt tablets recalled after bottles contained a lower strength tablet
FDA (Drugs) · 2025-09-17
- ModerateTeva Recalls Mixed Amphetamine Salts Tablets Due to Strength Variations
FDA (Drugs) · 2020-06-10
- HighTeva Recalls Mixed Amphetamine Salts Tablets Due to Mixed Strengths
FDA (Drugs) · 2020-06-10
- ModerateTeva Recalls Mixed Strength Amphetamine Salts Tablets
FDA (Drugs) · 2020-06-10
- ModerateAurobindo Recalls Amphetamine Mixed Salts Tablets for Out-of-Specification Weight
FDA (Drugs) · 2019-10-23
Same manufacturer · Teva Pharmaceuticals USA Inc
See all →- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- ModerateClaravis isotretinoin 10 mg capsules recalled for out-of-specification impurity
FDA (Drugs) · 2026-04-29
- ModerateTeva clonidine 0.2 mg patches recalled over unapproved raw material use
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 30 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Same hazard · mislabeling
See all →- ModerateOrthofix MINIRAIL External Fixation Devices Incorrectly Labeled
FDA (Devices) · 2026-07-22
- ModerateWise Onion Rings recalled for undeclared food color additives
FDA (Food) · 2026-07-15
- HighBakr Brown Butter Chocolate Chunk Cookie Dough Recalled for Undeclared Soy
FDA (Food) · 2026-07-15
- HighStapes prosthesis pistons carry an incorrect functional length on labeling
FDA (Devices) · 2026-06-10
- HighMedline eye trays contain insulin syringes labeled as tuberculin syringes
FDA (Devices) · 2026-06-03